Development of Therapies for Shiga Toxin

A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Bacterial Toxins".

Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 257

Special Issue Editor


E-Mail Website
Guest Editor
Molecular Medicine Peter Gilgan Centre for Research & Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON M5G 0A4, Canada
Interests: glycosphingolipids(GSLs); GSL metabolism; GSL traffic; GSL function; shiga toxin; verotoxin cholera toxin; globotriaosylceramide; glucosylceramide; endoplasmic reticulum associated degradation (ERAD)
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Gastrointestinal E. coli-derived Shiga toxin (verotoxin) remains the major cause of acute pediatric renal failure—the hemolytic uremic syndrome. Despite more than 30 years of research, there is no effective treatment to prevent the pathology of toxin-induced HUS. However, recent studies have expanded the scope and knowledge of Stx-induced pathology, and have sparked novel approaches to treatment/prevention which provide hope that effective therapy is on the horizon

Prof. Dr. Clifford A. Lingwood
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • toxin subunits
  • toxin family members
  • glycolipid receptors
  • cell carriers
  • complement
  • endothelial cells
  • podocytes
  • antibiotics
  • encephalopathy
  • retrograde transport

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop